## HON: Honeywell International Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.3% below STRENGTH zone (4.0-10.0%); PEG 1.83 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($187.49)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Honeywell Appoints Indra Nooyi To Board Of Directors**
- Source: TradingView | 20251210T120847 | Bullish | Relevance: 99%
-  Honeywell International Inc. has appointed Indra Nooyi as an independent director, effective January 1, 2026. This announcement, reported by Reuters, indicates a significant addition to Honeywell's board.

**2. Has Honeywellâ€™s Recent Share Price Slide Created a Long Term Opportunity in 2025?**
- Source: Simply Wall Street | 20251209T000819 | Somewhat-Bullish | Relevance: 99%
- Honeywell International's stock has seen a significant decline, dropping about 15.7% year-to-date and 10.0% over the last year, trading around $190.17. Despite this slide, a discounted cash flow analysis suggests the stock is undervalued by 14.6%, implying a fair value of $222.67 per share. Additionally, its current Price/Earnings ratio of 19.7x is below its proprietary "Fair Ratio" of 27.4x, further indicating potential undervaluation for long-term investors.

**3. HONEYWELL APPOINTS INDRA NOOYI TO BOARD OF DIRECTORS**
- Source: marketscreener.com | 20251210T120331 | Bullish | Relevance: 99%
-  Honeywell (NASDAQ: HON) announced the appointment of Indra Nooyi, former Chair and CEO of PepsiCo, to its Board of Directors as an Independent Director, effective January 1, 2026. Nooyi, 70, served as CEO of PepsiCo from 2006 to 2018 and is recognized for her "Performance with Purpose" strategy. Her extensive experience in leading diverse global businesses and her financial expertise are expected to contribute significantly to Honeywell's growth and shareholder value.

**4. Fayez Sarofim & Co Has $6.79 Million Holdings in Honeywell International Inc. $HON**
- Source: MarketBeat | 20251209T110849 | Somewhat-Bullish | Relevance: 99%
-  Fayez Sarofim & Co significantly increased its stake in Honeywell International Inc. by 35.5% during the second quarter, now holding 29,164 shares valued at approximately $6.79 million. Honeywell recently reported strong quarterly earnings of $2.25 EPS on $8.95 billion revenue, provided positive Q4 and FY2023 guidance, and raised its quarterly dividend to $1.19 per share. Analysts generally rate HON as a "Hold" with a consensus price target of $236.65, despite recent price objective reductions from several firms.

**5. Honeywell International Inc. (HON) Appoints Indra Nooyi as Indep**
- Source: GuruFocus | 20251210T160809 | Bullish | Relevance: 99%
- Honeywell International Inc. (HON) has appointed former PepsiCo CEO Indra Nooyi as an Independent Director to its Board, effective January 1, 2026. Ms. Nooyi brings extensive leadership and governance experience from her roles at PepsiCo, Amazon, and Philips. This appointment aims to strengthen Honeywell's strategic direction and innovation initiatives.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Barclays | $269 | $270 | -0% |
| 2025-11-18 | B of A Securiti | $205 | $265 | -23% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Barclays | main | Overweight |
| 2025-11-18 | B of A Securiti | down | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($0.12M) |
| Sells | 5 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (-0.3%)
- Blackrock Inc.: 7.1% (+6.1%)
- State Street Corpora: 4.4% (-0.8%)
- JPMORGAN CHASE & CO: 3.0% (+112.5%)
- Morgan Stanley: 2.7% (+0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.83 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 35%, margin 15%). Balance sheet: $2.9B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $130.6B |
| Beta | 0.95 |
| 52W Range | $169.05 - $227.82 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.83 |
| Forward P/E | 18.4 |
| Current P/E | 18.2 |
| YoY Growth | -0.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.2% to -1.3% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 5.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.0%) - potential reversal signal. Below SMA200 (0.96x), long-term trend not supportive. RSI neutral at 51.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.32% (CS: 36) | Neutral |
| RSI_14 | 50.9 | Neutral |
| MACD Histogram | 0.34 | Bullish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 0.993x | Below |
| vs SMA200 | 0.959x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $193.85
- **Stop Loss:** $187.49 (3.3% risk)
- **Target:** $200.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 216
- **Position Value:** $41,871.60
- **Portfolio %:** 41.87%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $2.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.57 | $2.82 | +9.9% |
| 2025Q2 | $2.66 | $2.75 | +3.4% |
| 2025Q1 | $2.21 | $2.51 | +13.6% |
| 2024Q4 | $2.35 | $2.47 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*